400 related articles for article (PubMed ID: 17002273)
1. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
[TBL] [Abstract][Full Text] [Related]
2. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.
Luo Y; Knuckley B; Lee YH; Stallcup MR; Thompson PR
J Am Chem Soc; 2006 Feb; 128(4):1092-3. PubMed ID: 16433522
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
4. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
[TBL] [Abstract][Full Text] [Related]
5. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.
Li D; Liu C; Lin J
J Mol Graph Model; 2015 Feb; 55():25-32. PubMed ID: 25424656
[TBL] [Abstract][Full Text] [Related]
6. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
[TBL] [Abstract][Full Text] [Related]
7. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
8. Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.
Knuckley B; Causey CP; Pellechia PJ; Cook PF; Thompson PR
Chembiochem; 2010 Jan; 11(2):161-5. PubMed ID: 20014086
[TBL] [Abstract][Full Text] [Related]
9. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
Slack JL; Causey CP; Luo Y; Thompson PR
ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
Subramanian V; Knight JS; Parelkar S; Anguish L; Coonrod SA; Kaplan MJ; Thompson PR
J Med Chem; 2015 Feb; 58(3):1337-44. PubMed ID: 25559347
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
12. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Knuckley B; Luo Y; Thompson PR
Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
[TBL] [Abstract][Full Text] [Related]
13. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.
Teo CY; Shave S; Chor AL; Salleh AB; Rahman MB; Walkinshaw MD; Tejo BA
BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S4. PubMed ID: 23282142
[TBL] [Abstract][Full Text] [Related]
15. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
Bozdag M; Dreker T; Henry C; Tosco P; Vallaro M; Fruttero R; Scozzafava A; Carta F; Supuran CT
Bioorg Med Chem Lett; 2013 Feb; 23(3):715-9. PubMed ID: 23265898
[TBL] [Abstract][Full Text] [Related]
16. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
[TBL] [Abstract][Full Text] [Related]
19. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.
Luo Y; Knuckley B; Bhatia M; Pellechia PJ; Thompson PR
J Am Chem Soc; 2006 Nov; 128(45):14468-9. PubMed ID: 17090024
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]